Surf Bio
Latest round
- Seed
Last raised
- Mar 2022
Total raised
- $16M
Investors
- 2
About Surf Bio
Founded in 2021 and based in California, US, Surf Bio, Inc. is a company that provides therapeutic solutions for diabetes, oncology, infectious diseases, gene therapy, and other diseases. In March 2022, Surf Bio, Inc. As of 2022, Bryan Mazlish is the CEO of the company. The company develops therapeutic solutions for diabetes, oncology, infectious illnesses, gene therapy, and other therapeutic areas using a surfactant. The firm is developing ultra-rapid insulin for diabetes treatment and is collaborating with pharmaceutical and biotech businesses to incorporate the stabilizing platform into its products. The organization plans to use the March 2022 funds for a polymer-based drug delivery platform and develop ultra-rapid insulin to treat diabetes.
Who invested in Surf Bio
2 investors across 1 round
See all investors in Surf Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 28, 2022
Amount
$16M
Investors
Questions about Surf Bio
Who invested in Surf Bio?
Surf Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Surf Bio raised?
Surf Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Surf Bio last raise money?
Surf Bio's most recent round on record is a Seed, in Mar 2022.
What does Surf Bio do?
Founded in 2021 and based in California, US, Surf Bio, Inc.
Where is Surf Bio headquartered?
Surf Bio is headquartered in Palo Alto, US.
Which VCs invest in companies like Surf Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Surf Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Surf Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.